• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Total Thyroidectomy Offers Lasting Benefit for Hashimoto Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 28, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 27, 2023 -- For patients with Hashimoto disease and persistent symptoms, total thyroidectomy is beneficial, offering long-lasting effects, according to a research letter published online Nov. 28 in the Annals of Internal Medicine.

Geir Hoff, M.D., Ph.D., from the University of Oslo in Norway, and colleagues examined long-term follow-up of a randomized trial of thyroidectomy plus medical management versus medical management alone for patients with Hashimoto disease, with persistent symptoms despite adequate thyroid hormone substitution. At inclusion, control patients were given the option of having surgery at 18 months after enrollment, depending on the trial results. Participants were followed up at five years in the intervention group and until date of surgery in the control group.

At baseline, 72 and 74 patients were included in the surgery and control groups, respectively. The researchers found that the positive treatment effect on the general health score, seen after 18 months, was maintained through three-year follow-up. The improved score remained at the same level in the intervention group during five-year follow-up. For the other Short Form-36 Health Survey domains and for total fatigue and chronic fatigue, results were similar. Short-term or longer-lasting complications occurred in 23 patients, including six with recurrent laryngeal nerve paralysis and 12 with hypoparathyroidism.

"Total thyroidectomy was shown to have a beneficial and long-lasting effect up to five years for patients with Hashimoto disease and persistent symptoms in an unblinded randomized clinical trial but with a substantially higher risk for complications than postulated at the beginning of the study," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.